–
CG Oncology, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY23 to FY25
millions USD
FY21:
FY22:
–
FY23:
−45.7
FY24:
−78.7
FY25:
−132
Change from FY21 to FY25
millions USD
FY21:
−0.10
FY22:
−55.4
FY23:
−121
FY24:
−301
FY25:
−246
Change from FY23 to FY25
millions USD
FY21:
–
FY22:
–
FY23:
87.0
FY24:
628
FY25:
154
millions USD
FY21:
–
FY22:
–
FY23:
−79.9
FY24:
249
FY25:
−225
(positive)
Change from FY21 to FY25
millions USD
FY21:
−13.8
FY22:
−29.8
FY23:
–
FY24:
−78.9
FY25:
−132
All amounts in millions USD FY21, FY22: figures supplemented from Twelve Data because the SEC filings do not reach back this far.